香港股市 將收市,收市時間:2 小時 36 分鐘

Cencora, Inc. (COR)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
235.68-1.52 (-0.64%)
收市:04:00PM EDT
235.68 0.00 (0.00%)
收市後: 05:16PM EDT

Cencora, Inc.

1 West First Avenue
Conshohocken, PA 19428-1800
United States
610 727 7000
https://www.cencora.com

版塊Healthcare
行業Medical Distribution
全職員工46,000

高階主管

名稱頭銜支付行使價出生年份
Mr. Steven H. CollisChairman, President & CEO5.01M13.79M1961
Mr. James F. Cleary Jr.Executive VP & CFO1.95M3.8M1963
Dr. Robert P. Mauch Ph.D., PharmDExecutive VP & COO2.7M1967
Ms. Gina K. ClarkExecutive VP and Chief Communications & Administration Officer1.57M5.01M1957
Ms. Elizabeth S. CampbellExecutive VP & Chief Legal Officer1.63M318.67k1975
Mr. Lazarus KrikorianSenior VP, Chief Accounting Officer & Corporate Controller1965
Bennett S. MurphySenior Vice President of Investor Relations
Ms. Jennifer E. DubasSenior VP & Chief Compliance Officer
Ms. Silvana BattagliaExecutive VP & Chief Human Resources Officer1.58M1968
Ms. Leslie E. DonatoExecutive VP & Chief Strategy Officer1970
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

公司管治

截至 2024年6月1日 止,Cencora, Inc. 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中:2;董事會:5;股東權利:7;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。